دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The saga of non-traditional risk factors continues with proteomics, microbiome, ozone, ketone bodies, and depression: let us rethink prevention
Filippo Crea
doi : 10.1093/eurheartj/ehad233
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1579–1582
Promises and challenges of machine learning for device therapy in heart failure
Nitesh Gautam, John Paul Mounsey, Edward T H Yeh, Subhi J Al’Aref
doi : 10.1093/eurheartj/ehad036
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1583–1585
Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease
Yaling Han
doi : 10.1093/eurheartj/ehad009
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1586–1588
Navigating your way through the internet maze to find reliable cardiovascular scientific information
Peter Lanzer, Nico Bruining
doi : 10.1093/eurheartj/ehad137
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1589–1591
‘Atom Heart Mothers’: the risk of ischaemic heart disease in women with adverse pregnancy outcomes
Rocco Vergallo, Carlo Patrono
doi : 10.1093/eurheartj/ehad166
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1592–1593
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Nick S Nurmohamed, Jordan M Kraaijenhof, Manuel Mayr, Stephen J Nicholls, Wolfgang Koenig, Alberico L Catapano, Erik S G Stroes
doi : 10.1093/eurheartj/ehad161
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1594–1607
Given the limited accuracy of clinically used risk scores such as the Systematic COronary Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores, novel risk algorithms determining an individual’s susceptibility of future incident or recurrent atherosclerotic cardiovascular disease (ASCVD) risk are urgently needed.
Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis
Meng Wang, Xinmin S Li, Zeneng Wang, Marcia C de Oliveira Otto, Rozenn N Lemaitre, Amanda Fretts, Nona Sotoodehnia, Matthew Budoff, Ina Nemet, Joseph A DiDonato, Wai Hong Wilson Tang, Bruce M Psaty, David S Siscovick, Stanley L Hazen, Dariush Mozaffarian
doi : 10.1093/eurheartj/ehad089
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1608–1618
Little is known about associations of trimethylamine N-oxide (TMAO), a novel gut microbiota-generated metabolite of dietary phosphatidylcholine and carnitine, and its changes over time with all-cause and cause-specific mortality in the general population or in different race/ethnicity groups.
They eat what we eat, they digest what we ingest
Thomas F Lüscher
doi : 10.1093/eurheartj/ehad104
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1619–1621
Ozone pollution and hospital admissions for cardiovascular events
Yunxing Jiang, Jing Huang, Guoxing Li, Wanzhou Wang, Kai Wang, Jinxi Wang, Chen Wei, Yinxiang Li, Furong Deng, Andrea A Baccarelli, Xinbiao Guo, Shaowei Wu
doi : 10.1093/eurheartj/ehad091
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1622–1632
The available literature on morbidity risk of cardiovascular diseases associated with ambient ozone pollution is still limited. This study examined the potential acute effects of exposure to ambient ozone pollution on hospital admissions of cardiovascular events in China.
The emergence of the air pollutant ozone as a significant cardiovascular killer?
Thomas Münzel, Omar Hahad, Andreas Daiber
doi : 10.1093/eurheartj/ehad046
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1633–1635
Circulating ketone bodies and cardiovascular outcomes: the MESA study
Elad Shemesh, Parag Anilkumar Chevli, Tareq Islam, Charles A German, James Otvos, Joseph Yeboah, Fatima Rodriguez, Christopher deFilippi, Joao A C Lima, Michael Blaha, Ambarish Pandey, Muthiah Vaduganathan, Michael D Shapiro
doi : 10.1093/eurheartj/ehad087
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1636–1646
Circulating ketone bodies as signals for cardiovascular disease and mortality
Suzanne N Voorrips, B Daan Westenbrink
doi : 10.1093/eurheartj/ehad176
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1647–1649
Psychological therapies for depression and cardiovascular risk: evidence from national healthcare records in England
Céline El Baou, Roopal Desai, Claudia Cooper, Natalie L Marchant, Steve Pilling, Marcus Richards, Rob Saunders, Joshua E J Buckman, Elisa Aguirre, Amber John, Joshua Stott
doi : 10.1093/eurheartj/ehad188
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1650–1662
People with depression are up to 72% more at risk to develop cardiovascular disease (CVD) in their lifetime. Evidence-based psychotherapies are first-line interventions for the treatment of depression and are delivered nationally in England through the National Health Service via the Improving Access to Psychological Therapy (IAPT) primary care programme.
Successful psychological treatment of depression and subsequent reduction in CVD events
David L Hare
doi : 10.1093/eurheartj/ehad173
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1663–1665
Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation
Takuya Kanamura, Toru Hashimoto, Akira Shiose, Hiroyuki Tsutsui
doi : 10.1093/eurheartj/ehad008
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Page 1666
Knock knock, who's there?: intracardiac giant thrombi
Tomoko S Kato, Daiki Hirayama, Susumu Manabe
doi : 10.1093/eurheartj/ehad092
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Page 1667
Protected by what injured him
Guoliang Li, Peizhu Dang, Yang Yan
doi : 10.1093/eurheartj/ehad113
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Page 1668
Erratum to: Iron deficiency and cardiovascular disease
doi : 10.1093/eurheartj/ehad043
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Page 1607
Erratum to: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
doi : 10.1093/eurheartj/ehad196
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Page 1621
